The 15 references in paper A. Taneeva Sh., A. Mudunov M., S. Alieva B., А. Танеева Ш., А. Мудунов М., С. Алиева Б. (2015) “СПОРНЫЕ ВОПРОСЫ В ЛЕЧЕНИИ БОЛЬНЫХ РАКОМ СКЛАДОЧНОГО ОТДЕЛА ГОРТАНИ T3N0–2M0 // CONTROVERSIAL ISSUES IN THE TREATMENT OF PATIENTS WITH T3N0–2M0 LARYNGEAL FOLD CANCER” / spz:neicon:ogsh:y:2014:i:2:p:10-13

1
Mantsopoulos K., Psychogios G., Bohr C. et al. Primary surgical treatment of T3 glottic carcinoma: long-term results and decision-making aspects. Laryngoscope
(check this in PDF content)
2
12;122:2723–7. 2. Ganly I., Patel S. G., Matsuo J. et al. Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head Neck 2009;31:1489–95.
(check this in PDF content)
3
Nguyen-Tan P. F., Le Q. T., Quivey J. M. et al. Treatment results and prognostic factors of advanced T3–4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 2001;50: 1172–80.
(check this in PDF content)
4
Lassaletta L., Garcia-Pallares M., Morera E. et al. T3 glottic cancer: oncologic results and prognostic factors. Otolaryngol Head Neck Surg 2001;124:556–60.
(check this in PDF content)
5
Nikolaou A., Markou K., Petridis D. et al. Factors influencing tumor relapse after total laryngectomy. B-ENT 2005;1:1–10.
(check this in PDF content)
6
Kowalski L. P., Batista M. B., Santos C. R. et al. Prognostic factors in T3, N0–1 glottic and transglottic carcinoma. A multifactorial study of 221 cases treated by surgery or radiotherapy. Arch Otolaryngol Head Neck Surg 1996;122:77–82.
(check this in PDF content)
7
Richard J. M., Sancho-Garnier H., Pessey J. J. et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 1998;34:224–8.
(check this in PDF content)
8
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685–90.
(check this in PDF content)
9
Forastiere A. A., Goepfert H., Maor M. et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091–8.
(check this in PDF content)
10
Forastiere A. A., Zhang Q., Weber R. S. et al. Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013;31:845–52.
(check this in PDF content)
11
Клинические рекомендации по лечению опухолей головы и шеи Общенациональной онкологической сети (США), National Comprehensive Cancer Network (NCCN), 2011.
(check this in PDF content)
12
Lefebvre J. L., Pointreau Y., Rolland F. et al. Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: the TREMPLIN Randomized PHASE II Study. J Clin Oncol 2013;31:853–9.
(check this in PDF content)
13
Argiris A., Ghebremichael M., Gilbert J. et al. Phase III randomized, placebocontrolled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol 2013;31:1405–14.
(check this in PDF content)
14
Basheeth N., O’Leary G., Khan H., Sheahan P. Oncologic outcomes of total laryngectomy: impact of margins and preoperative tracheostomy. Head Neck 2014 Mar 12.
(check this in PDF content)
15
Chen S. W., Yang S. N., Liang J. A. et al. Prognostic impact of tumor volume in patients with stage III–IVA hypopharyngeal cancer without bulcy lymph nodes treated with definitive concurrent
(check this in PDF content)